Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the consortium on the genetics of schizophrenia

American Journal of Psychiatry

Volumn 168, Issue 9, 2011, Pages 930-946

  Greenwood, Tiffany A ^{a,b,c,d,e,f,g,h,i,j,k,l}   Lazzeroni, Laura C ^{a,b,c,d,e,f,g,h,i,j,k,l}   Murray, Sarah S ^{a,b,c,d,e,f,g,h,i,j,k,l}   Cadenhead, Kristin S ^{a,b,c,d,e,f,g,h,i,j,k,l}   Calkins, Monica E ^{a,b,c,d,e,f,g,h,i,j,k,l}   Dobie, Dorcas J ^{a,b,c,d,e,f,g,h,i,j,k,l}   Green, Michael F ^{a,b,c,d,e,f,g,h,i,j,k,l}   Gur, Raquel E ^{a,b,c,d,e,f,g,h,i,j,k,l}   Gur, Ruben C ^{a,b,c,d,e,f,g,h,i,j,k,l}   Hardiman, Gary ^{a,b,c,d,e,f,g,h,i,j,k,l}   Kelsoe, John R ^{a,b,c,d,e,f,g,h,i,j,k,l}   Leonard, Sherry ^{a,b,c,d,e,f,g,h,i,j,k,l}   Light, Gregory A ^{a,b,c,d,e,f,g,h,i,j,k,l}   Nuechterlein, Keith H ^{a,b,c,d,e,f,g,h,i,j,k,l}   Olincy, Ann ^{a,b,c,d,e,f,g,h,i,j,k,l}   Radant, Allen D ^{a,b,c,d,e,f,g,h,i,j,k,l}   Schork, Nicholas J ^{a,b,c,d,e,f,g,h,i,j,k,l}   Seidman, Larry J ^{a,b,c,d,e,f,g,h,i,j,k,l}   Siever, Larry J ^{a,b,c,d,e,f,g,h,i,j,k,l}   Silverman, Jeremy M ^{a,b,c,d,e,f,g,h,i,j,k,l}   Stone, William S ^{a,b,c,d,e,f,g,h,i,j,k,l}   Swerdlow, Neal R ^{a,b,c,d,e,f,g,h,i,j,k,l}   Tsuang, Debby W ^{a,b,c,d,e,f,g,h,i,j,k,l}   Tsuang, Ming T ^{a,b,c,d,e,f,g,h,i,j,k,l}   Turetsky, Bruce I ^{a,b,c,d,e,f,g,h,i,j,k,l}   Freedman, Robert ^{a,b,c,d,e,f,g,h,i,j,k,l}   Braff, David L ^{a,b,c,d,e,f,g,h,i,j,k,l}   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID;

ADULT; AGED; ARTICLE; BOOTSTRAPPING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPHENOTYPE; FAMILY STUDY; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

COGNITION DISORDERS; ENDOPHENOTYPES; EPISTASIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 80051953863     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10050723     Document Type: Article

References (133)

1. Owen MJ, O'Donovan MC , Gottesman II: Schizophrenia, in Psychiatric Genetics and Genomics. Edited by McGuffin P, Owen MJ, Gottesman II. Oxford, UK, Oxford University Press, 2002, pp 247-266
2. Sullivan PF: The genetics of schizophrenia. PLoS Med 2005; 2(7):e212
3. Baron M: Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Genet 2001; 68:299-312
4. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC , Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy- Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, Helgason T: Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73:34-48
5. Owen MJ, Williams NM, O'Donovan MC: The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004; 9:14-27
6. Harrison PJ, Weinberger DR: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10:40-68
7. Gogos JA, Gerber DJ: Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 2006; 27:226-233
8. Braff DL, Freedman R: The importance of endophenotypes in studies of the genetics of schizophrenia, in Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C . Baltimore, Lippincott, Williams & Wilkins, 2002, pp 703-716
9. Braff DL, Freedman R, Schork NJ, Gottesman II: Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007; 33:21-32
10. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC , Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL: The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull 2007; 33:33-48
11. Nurnberger JI Jr, Blehar MC , Kaufmann CA, York-Cooler C , Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic Interview for Genetic Studies: rationale, unique features, and training: NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51:849-859; discussion, 863-864
12. Faraone SV, Tsuang D, Tsuang MT: Genetics of Mental Disorders: A Guide for Students, Clinicians, and Researchers. New York, Guilford, 1999
13. Gur RE, Calkins ME, Gur RC , Horan WP, Nuechterlein KH, Seidman LJ, Stone WS: The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull 2007; 33:49-68
14. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR: Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 2007; 33:69-94
15. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC , Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ: Initial heritability analyses of endophenotypic measures for schizophrenia: the Consortium on the Genetics of Schizophrenia. Arch Gen Psychiatry 2007; 64:1242-1250
16. Braff D, Stone C , Callaway E, Geyer M, Glick I, Bali L: Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978; 15:339-343
17. Braff DL, Geyer MA, Swerdlow NR: Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001; 156:234-258
18. Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL: Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res 2007; 92:237-251
19. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC , Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C , Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W: Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94:587-592
20. Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC , Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R: Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res 2010; 119:175-182
21. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW: Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res 2007; 89:320-329
22. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC , Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW: Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology 2010; 47:846-856
23. Nuechterlein KH, Parasuraman R, Jiang Q: Visual sustained attention: image degradation produces rapid sensitivity decrement over time. Science 1983; 220:327-329
24. Delis D, Kramer J, Kaplan E, Ober B: California Verbal Learning Test, 2nd ed. San Antonio, Tex, Psychological Corp, 2000
25. Gur RC , Ragland JD, Moberg PJ, Turner TH, Bilker WB, Kohler C , Siegel SJ, Gur RE: Computerized neurocognitive scanning, I: methodology and validation in healthy people. Neuropsychopharmacology 2001; 25:766-776
26. Gur RC , Ragland JD, Moberg PJ, Bilker WB, Kohler C , Siegel SJ, Gur RE: Computerized neurocognitive scanning, II: the profile of schizophrenia. Neuropsychopharmacology 2001; 25:777-788
27. Hemminger BM, Saelim B, Sullivan PF: TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits. Bioinformatics 2006; 22:626-627
28. International HapMap Consortium: A haplotype map of the human genome. Nature 2005; 437:1299-1320
29. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 2005; 37:1217-1223
30. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C , Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229
31. Gault J, Robinson M, Berger R, Drebing C , Logel J, Hopkins J, Moore T, Jacobs S, Meriwether J, Choi MJ, Kim EJ, Walton K, Buiting K, Davis A, Breese C , Freedman R, Leonard S: Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998; 52:173-185
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575
33. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62:1198-1211
34. Abecasis GR, Cherny SS, Cookson WO, Cardon LR: Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30:97-101
35. Nyholt DR: A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-769
36. Lazzeroni LC , Lange K: A conditional inference framework for extending the transmission/disequilibrium test. Hum Hered 1998; 48:67-81
37. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. New York, Chapman & Hall, 1993
38. Kukreti R, Tripathi S, Bhatnagar P, Gupta S, Chauhan C , Kubendran S, Janardhan Reddy YC , Jain S, Brahmachari SK: Association of DRD2 gene variant with schizophrenia. Neurosci Lett 2006; 392:68-71
39. Nakajima M, Hattori E, Yamada K, Iwayama Y, Toyota T, Iwata Y, Tsuchiya KJ, Sugihara G, Hashimoto K, Watanabe H, Iyo M, Hoshika A, Yoshikawa T: Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics. J Hum Genet 2007; 52:86-91
40. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE: Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 2005; 77:918-936
41. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C , Ingason A, Gulcher JR, Stefansson K, St Clair D: Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72:83-87
42. Hall D, Gogos JA, Karayiorgou M: The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 2004; 3:240-248
43. Fukui N, Muratake T, Kaneko N, Amagane H, Someya T: Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population. Neurosci Lett 2006; 396:117-120
44. Li D, Collier DA, He L: Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006; 15:1995-2002
45. Stefanis NC , Trikalinos TA, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani EE, Ioannidis JP, Stefanis CN: Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 2007; 62:784-792
46. Liu YL, Fann CS, Liu CM, Chang CC , Yang WC , Hung SI, Yu SL, Hwang TJ, Hsieh MH, Liu CC , Tsuang MM, Wu JY, Jou YS, Faraone SV, Tsuang MT, Chen WJ, Hwu HG: More evidence supports the association of PPP3CC with schizophrenia. Mol Psychiatry 2007; 12:966-974
47. Li T, Ma X, Sham PC , Sun X, Hu X, Wang Q, Meng H, Deng W, Liu X, Murray RM, Collier DA: Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population. Am J Med Genet B Neuropsychiatr Genet 2004; 129:13-15
48. Deng X, Shibata H, Ninomiya H, Tashiro N, Iwata N, Ozaki N, Fukumaki Y: Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia. BMC Psychiatry 2004; 4:21 (http://www. biomedcentral. com/1471-244X/4/21)
49. Barrett TB, Emberton JE, Nievergelt CM, Liang SG, Hauger RL, Eskin E, Schork NJ, Kelsoe JR: Further evidence for association of GRK3 to bipolar disorder suggests a second disease mutation. Psychiatr Genet 2007; 17:315-322
50. Schwab SG, Hoefgen B, Hanses C , Hassenbach MB, Albus M, Lerer B, Trixler M, Maier W, Wildenauer DB: Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 2005; 58:446-450
51. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Inada T, Ozaki N: Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 2004; 56:698-700
52. Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, Fayyazi MR, Sargolzaee MR, Bajestan MN, Sabouri Z, Khayami E, Haghighi S, Hashemi SB, Eiraku N, Tufani H, Najmabadi H, Arimura K, Sano A, Osame M: Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet 2006; 141:383-386
53. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C , Walker N, St Clair DM: BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005; 10:208-212
54. Liang SG, Shekhtman T, Gaucher MA, Barrett TB, Schork NJ, Berrettini WH, Byerley W, Coryell W, Gershon ES, McInnis MG, DePaulo JR, Nurnberger JI, Rice JR, Scheftner W, McMahon FJ, Kelsoe JR: High density SNP association study of 22q13 identifies CACGN2 as a susceptibility locus for bipolar disorder in two independent samples (abstract). Am J Med Genet B Neuropsychiatr Genet 2005; 138B:27
55. Stephens SH, Logel J, Barton A, Franks A, Schultz J, Short M, Dickenson J, James B, Fingerlin TE, Wagner B, Hodgkinson C , Graw S, Ross RG, Freedman R, Leonard S: Association of the 5;-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res 2009; 109:102-112
56. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS: Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 2004; 9:962-967
57. Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, DeRosse P, Kane JM, Kucherlapati R: COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 2005; 1:19 (http://www.behavioralandbrainfunctions. com/content/1/1/19)
58. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR: Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 2006; 11:867-877, 797
59. Schurhoff F, Szoke A, Chevalier F, Roy I, Meary A, Bellivier F, Giros B, Leboyer M: Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele. Am J Med Genet B Neuropsychiatr Genet 2007; 144:64-68
60. Liu X, He G, Wang X, Chen Q, Qian X, Lin W, Li D, Gu N, Feng G, He L: Association of DAAO with schizophrenia in the Chinese population. Neurosci Lett 2004; 369:228-233
61. Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte AC , Tullius M, Kovalenko S, Bogaert AV, Maier W, Rietschel M, Propping P, Nothen MM, Cichon S: Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9:203-207
62. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C , Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C , Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC , Straub RE, Weinberger DR, Cohen N, Cohen D: Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99:13675-13680
63. Hattori E, Liu C , Badner JA, Bonner TI, Christian SL, Maheshwari M, Detera-Wadleigh SD, Gibbs RA, Gershon ES: Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003; 72:1131-1140
64. Addington AM, Gornick M, Sporn AL, Gogtay N, Greenstein D, Lenane M, Gochman P, Baker N, Balkissoon R, Vakkalanka RK, Weinberger DR, Straub RE, Rapoport JL: Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55:976-980
65. Ma J, Qin W, Wang XY, Guo TW, Bian L, Duan SW, Li XW, Zou FG, Fang YR, Fang JX, Feng GY, Gu NF, St Clair D, He L: Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations. Mol Psychiatry 2006; 11:479-487
66. Korostishevsky M, Kremer I, Kaganovich M, Cholostoy A, Murad I, Muhaheed M, Bannoura I, Rietschel M, Dobrusin M, Bening-Abu-Shach U, Belmaker RH, Maier W, Ebstein RP, Navon R: Transmission disequilibrium and haplotype analyses of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in the north of Israel. Am J Med Genet B Neuropsychiatr Genet 2006; 141:91-95
67. Yue W, Kang G, Zhang Y, Qu M, Tang F, Han Y, Ruan Y, Lu T, Zhang J, Zhang D: Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 2007; 416:96-100
68. Shifman S, Levit A, Chen ML, Chen CH, Bronstein M, Weizman A, Yakir B, Navon R, Darvasi A: A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia. Hum Genet 2006; 120:160-170
69. Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, Haukka J, Parker A, Martin R, Levitzky S, Partonen T, Meyer J, Lonnqvist J, Peltonen L, Ekelund J: Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 2003; 12:3151-3159
70. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR: Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 2005; 102:8627-8632
71. Liu YL, Fann CS, Liu CM, Chen WJ, Wu JY, Hung SI, Chen CH, Jou YS, Liu SK, Hwang TJ, Hsieh MH, Ouyang WC , Chan HY, Chen JJ, Yang WC , Lin CY, Lee SF, Hwu HG: A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biol Psychiatry 2006; 60:554-562
72. Zhang F, Sarginson J, Crombie C , Walker N, St Clair D, Shaw D: Genetic association between schizophrenia and the DISC1 gene in the Scottish population. Am J Med Genet B Neuropsychiatr Genet 2006; 141:155-159
73. Chen QY, Chen Q, Feng GY, Lindpaintner K, Wang LJ, Chen ZX, Gao ZS, Tang JS, Huang G, He L: Case-control association study of disrupted-in-schizophrenia- 1 (DISC1) gene and schizophrenia in the Chinese population. J Psychiatr Res 2007; 41:428-434
74. Qu M, Tang F, Yue W, Ruan Y, Lu T, Liu Z, Zhang H, Han Y, Zhang D, Wang F: Positive association of the disrupted-in-schizophrenia- 1 gene (DISC1) with schizophrenia in the Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2007; 144:266-270
75. DeRosse P, Hodgkinson CA, Lencz T, Burdick KE, Kane JM, Goldman D, Malhotra AK: Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry 2007; 61:1208-1210
76. Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, Levitt P, Lewis DA, Li T, Mirnics K, Morris DW, Norton N, O'Donovan MC , Owen MJ, Richard C , Semwal P, Sobell JL, St Clair D, Straub RE, Thelma BK, Vallada H, Weinberger DR, Williams NM, Wood J, Zhang F, Devlin B, Nimgaonkar VL: Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 2006; 60:152-162
77. Dominguez E, Loza MI, Padin F, Gesteira A, Paz E, Paramo M, Brenlla J, Pumar E, Iglesias F, Cibeira A, Castro M, Caruncho H, Carracedo A, Costas J: Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophr Res 2007; 90:123-129
78. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C , Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS: Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71:337-348
79. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB: Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sibpair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72:185-190
80. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, Riley BP: Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 2003; 8:499-510
81. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, Kucherlapati R, Malhotra AK: Association of the DTNBP1 locus with schizophrenia in a US population. Am J Hum Genet 2004; 75:891-898
82. Li T, Zhang F, Liu X, Sun X, Sham PC , Crombie C , Ma X, Wang Q, Meng H, Deng W, Yates P, Hu X, Walker N, Murray RM, St Clair D, Collier DA: Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol Psychiatry 2005; 10:1037-1044
83. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R: The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 2006; 141:142-148
84. Lo WS, Lau CF, Xuan Z, Chan CF, Feng GY, He L, Cao ZC , Liu H, Luan QM, Xue H: Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia. Mol Psychiatry 2004; 9:603-608
85. Lo WS, Harano M, Gawlik M, Yu Z, Chen J, Pun FW, Tong KL, Zhao C , Ng SK, Tsang SY, Uchimura N, Stober G, Xue H: GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes. Biol Psychiatry 2007; 61:653-660
86. Yu Z, Chen J, Shi H, Stoeber G, Tsang SY, Xue H: Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clin Biochem 2006; 39:210-218
87. Addington AM, Gornick M, Duckworth J, Sporn A, Gogtay N, Bobb A, Greenstein D, Lenane M, Gochman P, Baker N, Balkissoon R, Vakkalanka RK, Weinberger DR, Rapoport JL, Straub RE: GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 2005; 10:581-588
88. Shibata H, Aramaki T, Sakai M, Ninomiya H, Tashiro N, Iwata N, Ozaki N, Fukumaki Y: Association study of polymorphisms in the GluR7, KA1 and KA2 kainate receptor genes (GRIK3, GRIK4, GRIK5) with schizophrenia. Psychiatry Res 2006; 141:39-51
89. Pickard BS, Malloy MP, Christoforou A, Thomson PA, Evans KL, Morris SW, Hampson M, Porteous DJ, Blackwood DH, Muir WJ: Cytogenetic and genetic evidence supports a role for the kainate- type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol Psychiatry 2006; 11:847-857
90. Zhao X, Li H, Shi Y, Tang R, Chen W, Liu J, Feng G, Shi J, Yan L, Liu H, He L: Significant association between the genetic variations in the 5; end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry 2006; 59:747-753
91. Ohtsuki T, Sakurai K, Dou H, Toru M, Yamakawa-Kobayashi K, Arinami T: Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol Psychiatry 2001; 6:211-216
92. Di Maria E, Gulli R, Begni S, De Luca A, Bignotti S, Pasini A, Bellone E, Pizzuti A, Dallapiccola B, Novelli G, Ajmar F, Gennarelli M, Mandich P: Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. Am J Med Genet B Neuropsychiatr Genet 2004; 128:27-29
93. Li D, He L: Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a huge review and meta-analysis. Genet Med 2007; 9:4-8
94. Fujii Y, Shibata H, Kikuta R, Makino C , Tani A, Hirata N, Shibata A, Ninomiya H, Tashiro N, Fukumaki Y: Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 2003; 13:71-76
95. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C , Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR: Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004; 101:12604-12609
96. Chen Q, He G, Wu S, Xu Y, Feng G, Li Y, Wang L, He L: A casecontrol study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res 2005; 73:21-26
97. Baritaki S, Rizos E, Zafiropoulos A, Soufla G, Katsafouros K, Gourvas V, Spandidos DA: Association between schizophrenia and DRD3 or HTR2 receptor gene variants. Eur J Hum Genet 2004; 12:535-541
98. Golimbet VE, Lavrushina OM, Kaleda VG, Abramova LI, Lezheiko TV: Supportive evidence for the association between the T102C 5-HTR2A gene polymorphism and schizophrenia: a large-scale case-control and family-based study. Eur Psychiatry 2007; 22:167-170
99. Ikeda M, Iwata N, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y, Ozaki N: Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology 2006; 31:866-871
100. Sullivan PF, Keefe RS, Lange LA, Lange EM, Stroup TS, Lieberman J, Maness PF: NCAM1 and neurocognition in schizophrenia. Biol Psychiatry 2007; 61:902-910
101. Atz ME, Rollins B, Vawter MP: NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr Genet 2007; 17:55-67
102. Fanous AH, Chen X, Wang X, Amdur RL, O'Neill FA, Walsh D, Kendler KS: Association between the 5q31.1 gene neurogenin1 and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2007; 144:207-214
103. Zhang X, Wei J, Yu YQ, Liu SZ, Shi JP, Liu LL, Ju GZ, Yang JZ, Zhang D, Xu Q, Shen Y, Hemmings GP: Is NOTCH4 associated with schizophrenia? Psychiatr Genet 2004; 14:43-46
104. Wang Z, Wei J, Zhang X, Guo Y, Xu Q, Liu S, Shi J, Yu Y, Ju G, Li Y, Shen Y: A review and re-evaluation of an association between the NOTCH4 locus and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006; 141:902-906
105. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR: Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 2007; 117:672-682
106. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, Thelma BK, Ferrell RE, Middleton FA, Devlin B, Levitt P, Lewis DA, Nimgaonkar VL: Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11:1373-1380
107. Chen X, Dunham C , Kendler S, Wang X, O'Neill FA, Walsh D, Kendler KS: Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet 2004; 129:23-26
108. Morris DW, Rodgers A, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP: Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004; 125:50-53
109. Talkowski ME, Mansour H, Chowdari KV, Wood J, Butler A, Varma PG, Prasad S, Semwal P, Bhatia T, Deshpande S, Devlin B, Thelma BK, Nimgaonkar VL: Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biol Psychiatry 2006; 60:570-577
110. Richards M, Iijima Y, Kondo H, Shizuno T, Hori H, Arima K, Saitoh O, Kunugi H: Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population. Behav Brain Funct 2006; 2:39 (http://www. behavioralandbrainfunctions.com/content/2/1/39)
111. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR: Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 2006; 11:125-133
112. Zhou X, Tang W, Greenwood TA, Guo S, He L, Geyer MA, Kelsoe JR: Transcription factor SP4 as a susceptibility gene for bipolar disorder. PLoS One 2009; 4(4):e5196
113. Duan J, Martinez M, Sanders AR, Hou C , Saitou N, Kitano T, Mowry BJ, Crowe RR, Silverman JM, Levinson DF, Gejman PV: Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 2004; 75:624-638
114. Pae CU, Yu HS, Amann D, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH, Patkar AA, Lerer B: Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. J Psychiatr Res 2008; 42:35-40
115. Mukai J, Liu H, Burt RA, Swor DE, Lai WS, Karayiorgou M, Gogos JA: Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 2004; 36:725-731
116. Chen WY, Shi YY, Zheng YL, Zhao XZ, Zhang GJ, Chen SQ, Yang PD, He L: Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet 2004; 13:2991-2995
117. Coyle JT: Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26:365-384
118. Sodhi M, Wood KH, Meador-Woodruff J: Role of glutamate in schizophrenia:
119. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C , Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC , Sebat J: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320:539-543
120. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71:877-892
121. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S, O'Donovan MC , Owen MJ: Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003; 8:485-487
122. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D, Clair DS, Waddington JL, Gill M: Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs 97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004; 9:208-213
123. Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ: Advances in endophenotyping schizophrenia. World Psychiatry 2008; 7:11-18
124. Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R, Sanfilipo M, Chappell PB, Chakravorty S, Gonzenbach S, Ko GN, Rotrosen JP: Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 2000; 47:662-669
125. Kumari V, Sharma T: Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) 2002; 162:97-101
126. Duncan EJ, Szilagyi S, Efferen TR, Schwartz MP, Parwani A, Chakravorty S, Madonick SH, Kunzova A, Harmon JW, Angrist B, Gonzenbach S, Rotrosen JP: Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology (Berl) 2003; 167:63-71
127. Ozaki M, Sasner M, Yano R, Lu HS, Buonanno A: Neuregulinbeta induces expression of an NMDA-receptor subunit. Nature 1997; 390:691-694
128. Rieff HI, Raetzman LT, Sapp DW, Yeh HH, Siegel RE, Corfas G: Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 1999; 19:10757-10766
129. Anton ES, Ghashghaei HT, Weber JL, McCann C , Fischer TM, Cheung ID, Gassmann M, Messing A, Klein R, Schwab MH, Lloyd KC , Lai C: Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 2004; 7:1319-1328
130. Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, Binder EB, Cubells J, Ehlers CL, Gelernter J, Mann J, Riley B, Roy A, Tabakoff B, Todd RD, Zhou Z, Goldman D: Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 2008; 43:505-515
131. Platt JR: Strong inference: certain systematic methods of scientific thinking may produce much more rapid progress than others. Science 1964; 146:347-353
132. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C , Burrell GJ, Rice JP, Nertney DA, Olincy A, Rozic P, Vinogradov S, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Crowe RR, Cloninger CR, Martinez M, Gejman PV: No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008; 165:497-506
133. McClellan J, King MC: Genetic heterogeneity in human disease. Cell 2010; 141:210-217